Zobrazeno 1 - 10
of 966
pro vyhledávání: '"Tarantelli, C"'
Autor:
Santachiara, Teofilo
Publikováno v:
Il Foro Italiano, 1910 Jan 01. 35, 179/180-195/196.
Externí odkaz:
https://www.jstor.org/stable/23112849
Autor:
Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Scalise L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cacciapuoti MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Stathis A; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Van Berkel PH; ADC Therapeutics (UK) Ltd., London, UK., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Zammarchi F; ADC Therapeutics (UK) Ltd., London, UK., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jul 30. Date of Electronic Publication: 2024 Jul 30.
Autor:
Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Mascia M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Barreca M; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy., Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Licenziato L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Department of Veterinary Sciences, University of Turin, Turin, Italy., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Ferragamo A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Pileri S; Division of Diagnostic Haematopathology, European Institute of Oncology, Milan, Italy., Damia G; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Politz O; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany., Wengner AM; Bayer AG, Pharmaceuticals, Research & Development, Berlin, Germany., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 191-205. Date of Electronic Publication: 2023 Nov 27.
Autor:
Arribas AJ; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland., Napoli S; Institute of Oncology Research, Bellinzona, Switzerland., Gaudio E; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland., Herbaux C; CHU Montpellier UMR5535, Montpellier, France., Cannas E; 1 Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Bordone Pittau R; IOSI Oncology Institute of Southern Switzerland., Cascione L; IOR - Institute of Oncology Research, Bellinzona, Switzerland., Munz N; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Aresu L; University of Turin, Grugliasco, Italy., Sgrignani J; Institute of Research in Biomedicine, Bellinzona, Switzerland., Rinaldi A; Institute of Oncology Research, Bellinzona, Switzerland., Kwee I; BigOmics Analytics SA, Lugano, Switzerland., Rossi D; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Cavalli A; Università della Svizzera italiana, Bellonzona, Switzerland., Zucca E; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Stussi G, Stathis A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzoona, Switzerland., Sloss C; ImmunoGen, Inc., Davids MS; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.
Publikováno v:
Blood advances [Blood Adv] 2024 Oct 07. Date of Electronic Publication: 2024 Oct 07.
Autor:
Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona. chiara.tarantelli@ior.usi.ch., Wald D; Case Western Reserve University, Cleveland, OH., Munz N; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Bruscaggin A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cannas E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne., Manjappa S; Fred Hutchinson Cancer Center, Seattle, Washington., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Scalise L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cacciapuoti MT; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona., Stathis A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; Faculty of Biomedical Sciences, USI, Lugano., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Van Berkel PH; ADC Therapeutics (UK) Ltd., London., Rossi D; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona., Caimi PF; Cleveland Clinic/Case Comprehensive Cancer Center, Cleveland, OH., Zammarchi F; ADC Therapeutics (UK) Ltd., London., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona. francesco.bertoni@ior.usi.ch.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 01; Vol. 109 (10), pp. 3314-3326. Date of Electronic Publication: 2024 Oct 01.
Autor:
Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Sgrignani J; Institute of Research in Biomedicine, Faculty of Biomedical Sciences, USI, Bellinzona., Barnabei L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne., Guala M; Chimete, Tortona., Del Amor AMC; Department of Biomedical and Clinical Sciences, Cell Biology, Medical Faculty, Linköping University, Linköping., Tomasso MR; Drexel University, College of Medicine, Department of Biochemistry and Molecular Biology, Philadelphia, PA., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Department of Pharmacy, University of Napoli Federico II, Napoli., Riveiro ME; Early Drug Development Group, Boulogne-Billancourt., Bortolozzi R; Department of Woman's and Child's Health, University of Padova, Italy; Istituto di Ricerca Pediatrica IRP, Fondazione Città della Speranza, Padova., Lupia A; Department of Pharmacy, University of Napoli Federico II, Napoli, Italy; Net4science Srl, Magna Graecia University of Catanzaro, Catanzaro., Paduano F; University 'Magna Græcia' of Catanzaro, Catanzaro, Italy; Tecnologica Research Institute and Marrelli Health, Biomedical Section, Stem Cells and Medical Genetics Units, Crotone., Huguet S; Institut Curie, Paris., Rezai K; Institut Curie, Paris., Rinaldi A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Margheriti F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Ventura P; Institute of Research in Biomedicine, Faculty of Biomedical Sciences, USI, Bellinzona., Guarda G; Institute of Research in Biomedicine, Faculty of Biomedical Sciences, USI, Bellinzona., Costa G; University 'Magna Græcia' of Catanzaro, Catanzaro., Rocca R; University 'Magna Græcia' of Catanzaro, Catanzaro., Furlan A; Institute of Research in Biomedicine, Faculty of Biomedical Sciences, USI, Bellinzona., Verdonk LM; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Leiden., Innocenti P; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Leiden., Martin NI; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Leiden., Viola G; Department of Woman's and Child's Health, University of Padova, Italy; Istituto di Ricerca Pediatrica IRP, Fondazione Città della Speranza, Padova., Driessen C; Kantosspital St Gallen, St Gallen., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona., Stathis A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona., Gahtory D; BIMINI Biotech B.V., Leiden., Van den Nieuwboer M; BIMINI Biotech B.V., Leiden., Bornhauser B; Children's Hospital Zurich, Zurich., Alcaro S; University 'Magna Græcia' of Catanzaro, Catanzaro., Trapasso F; University 'Magna Græcia' of Catanzaro, Catanzaro., Cristobal S; Department of Biomedical and Clinical Sciences, Cell Biology, Medical Faculty, Linköping University, Linköping, Sweden; Ikerbasque, Basque Foundation for Sciences, Department of Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country., Padrick SB; Drexel University, College of Medicine, Department of Biochemistry and Molecular Biology, Philadelphia, PA., Pazzi N; Chimete, Tortona., Cavalli F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona., Cavalli A; Institute of Research in Biomedicine, Faculty of Biomedical Sciences, USI, Bellinzona., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona. eugaudio1976@gmail.com., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona. francesco.bertoni@ior.usi.ch.
Publikováno v:
Haematologica [Haematologica] 2024 Jun 20. Date of Electronic Publication: 2024 Jun 20.
Autor:
Licenziato L; Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy., Mazzone E; Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland., Accornero P; Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy., Rinaldi A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland., Divari S; Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy., Leung W; Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA., Webb S; Velocity Clinical Research, Binghamton, NY 13905, USA., De Maria R; Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy., Aresu L; Department of Veterinary Sciences, University of Turin, 10095 Grugliasco, Italy.
Publikováno v:
Animals : an open access journal from MDPI [Animals (Basel)] 2024 May 15; Vol. 14 (10). Date of Electronic Publication: 2024 May 15.
Autor:
Forestieri G; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., de Almeida JM; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Napoli S; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Piffaretti D; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Tarantelli C; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Zhang F; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Mensah AA; Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
Publikováno v:
Hematological oncology [Hematol Oncol] 2024 May; Vol. 42 (3), pp. e3275.
Autor:
Zammarchi F; ADC Therapeutics (UK) Ltd, London, United Kingdom., Havenith KE; ADC Therapeutics (UK) Ltd, London, United Kingdom., Sachini N; ADC Therapeutics (UK) Ltd, London, United Kingdom., Janghra N; ADC Therapeutics (UK) Ltd, London, United Kingdom., Chivers S; ADC Therapeutics (UK) Ltd, London, United Kingdom., Idusogie E; ADC Therapeutics America, Inc, Murray Hill, United States., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Bertelli F; AstraZeneca (MedImmune/Spirogen), London, United Kingdom., Santos K; AstraZeneca (MedImmune/Spirogen), London, United Kingdom., Tyrer P; AstraZeneca (MedImmune/Spirogen), London, United Kingdom., Corbett S; University College London, London, United Kingdom., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Golino G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland., Hartley JA; University College London, London, United Kingdom., van Berkel PH; ADC Therapeutics (UK) Ltd, London, United Kingdom.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Apr 02; Vol. 23 (4), pp. 520-531.
Autor:
Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Napoli S; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Barnabei L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cannas E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Mensah AA; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Zucchetto A; Centro di Riferimento Oncologico di Aviano - CRO, Aviano, Italy., Rossi FM; Centro di Riferimento Oncologico di Aviano - CRO, Aviano, Italy., Rinaldi A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Castro de Moura M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain., Jovic S; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Bordone Pittau R; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Stathis A; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Stussi G; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Gattei V; Centro di Riferimento Oncologico di Aviano - CRO, Aviano, Italy., Brown JR; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain., Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Rossi D; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Mar 04; Vol. 23 (3), pp. 368-380.